These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7535085)

  • 1. 11q13 amplification in local recurrence of human primary breast cancer.
    Champème MH; Bièche I; Lizard S; Lidereau R
    Genes Chromosomes Cancer; 1995 Feb; 12(2):128-33. PubMed ID: 7535085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An attempt to define sets of cooperating genetic alterations in human breast cancer.
    Cheickh MB; Rouanet P; Louason G; Jeanteur P; Theillet C
    Int J Cancer; 1992 Jun; 51(4):542-7. PubMed ID: 1351044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of genetic alterations related to the development and progression of breast carcinoma.
    Nagayama K; Watatani M
    Jpn J Cancer Res; 1993 Nov; 84(11):1159-64. PubMed ID: 7903963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer.
    Karlseder J; Zeillinger R; Schneeberger C; Czerwenka K; Speiser P; Kubista E; Birnbaum D; Gaudray P; Theillet C
    Genes Chromosomes Cancer; 1994 Jan; 9(1):42-8. PubMed ID: 7507699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.
    Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
    Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
    Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of high-risk breast cancer patients from genetic changes of their tumors.
    Watatani M; Inui H; Nagayama K; Imanishi Y; Nishimura K; Hashimoto Y; Yamauchi E; Hojo T; Kotsuma Y; Yamato M; Matsunami N; Yasutomi M
    Surg Today; 2000; 30(6):516-22. PubMed ID: 10883462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy.
    Lizard-Nacol S; Lidereau R; Collin F; Arnal M; Hahnel L; Roignot P; Cuisenier J; Guerrin J
    Cancer Res; 1995 Oct; 55(19):4416-9. PubMed ID: 7671254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.
    Schuuring E; Verhoeven E; van Tinteren H; Peterse JL; Nunnink B; Thunnissen FB; Devilee P; Cornelisse CJ; van de Vijver MJ; Mooi WJ
    Cancer Res; 1992 Oct; 52(19):5229-34. PubMed ID: 1394126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.
    Bièche I; Champème MH; Lidereau R
    Cancer Res; 1994 Aug; 54(16):4274-6. PubMed ID: 7913873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutations and human breast cancer. A status report.
    Callahan R; Cropp CS; Merlo GR; Liscia DS; Cappa AP; Lidereau R
    Cancer; 1992 Mar; 69(6 Suppl):1582-8. PubMed ID: 1540899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms.
    Matsuo K; Tang SH; Fagin JA
    Mol Endocrinol; 1991 Dec; 5(12):1873-9. PubMed ID: 1791835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
    Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite analysis of breast carcinoma and corresponding local recurrences.
    Regitnig P; Moser R; Thalhammer M; Luschin-Ebengreuth G; Ploner F; Papadi H; Tsybrovskyy O; Lax SF
    J Pathol; 2002 Oct; 198(2):190-7. PubMed ID: 12237878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
    Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.
    Thorstensen L; Qvist H; Heim S; Liefers GJ; Nesland JM; Giercksky KE; Lothe RA
    Neoplasia; 2000; 2(6):514-22. PubMed ID: 11228544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic abnormalities, genetic alterations, and applications for genetic diagnosis in breast cancer].
    Tsukamoto K; Emi M; Nakamura Y
    Nihon Rinsho; 1996 Dec; 54(12):3389-97. PubMed ID: 8976125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.